Research programme: retinoic acid derivatives - sigma-tauAlternative Names: ST 1898
Latest Information Update: 29 Sep 2010
At a glance
- Originator sigma-tau SpA
- Class Retinoids
- Mechanism of Action Apoptosis stimulants; Retinoic acid receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 05 Mar 2007 Preclinical trials in Acne in Italy (unspecified route)